Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
41.83
-1.38 (-3.19%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Merus Employees
As of December 31, 2024, Merus had 321 total employees, including 260 full-time and 61 part-time employees. The number of employees increased by 92 or 40.17% compared to the previous year.
Employees
321
Change (1Y)
92
Growth (1Y)
40.17%
Revenue / Employee
$112,564
Profits / Employee
-$670,798
Market Cap
2.89B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
MRUS News
- 22 hours ago - Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting - GlobeNewsWire
- 17 days ago - Merus: Riding The Bispecific Wave In Oncology - Seeking Alpha
- 23 days ago - Merus to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Merus Announces Financial Results for the Fourth Quarter and Full Year 2024 and Provides Business Update - GlobeNewsWire
- 2 months ago - Merus to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Petosemtamab granted Breakthrough Therapy designation by the U.S. FDA for 1L PD-L1 positive head and neck squamous cell carcinoma - GlobeNewsWire
- 2 months ago - Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit - GlobeNewsWire
- 2 months ago - New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer - GlobeNewsWire